209 related articles for article (PubMed ID: 36008461)
21. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.
Tachibana K; Nakamura Y; Do TL; Kihara T; Kawada H; Yamamoto N; Ando K
Biochem Biophys Res Commun; 2024 Jul; 719():150120. PubMed ID: 38759524
[TBL] [Abstract][Full Text] [Related]
23. Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor.
Sultana N; Nagesha SN; Reddy CNL; Ramesh BN; Shyamalamma S; Shashidhara KS; Satish KM; Pradeep C; Vidyadhar GD
Virol J; 2024 Apr; 21(1):88. PubMed ID: 38641844
[TBL] [Abstract][Full Text] [Related]
24. In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding.
Bate N; Savva CG; Moody PCE; Brown EA; Evans SE; Ball JK; Schwabe JWR; Sale JE; Brindle NPJ
PLoS Pathog; 2022 Jul; 18(7):e1010733. PubMed ID: 35849637
[TBL] [Abstract][Full Text] [Related]
25. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
26. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
[TBL] [Abstract][Full Text] [Related]
27. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
28. Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2.
Gong SY; Ding S; Benlarbi M; Chen Y; Vézina D; Marchitto L; Beaudoin-Bussières G; Goyette G; Bourassa C; Bo Y; Medjahed H; Levade I; Pazgier M; Côté M; Richard J; Prévost J; Finzi A
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298733
[TBL] [Abstract][Full Text] [Related]
29. Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution.
Erausquin E; Glaser F; Fernández-Recio J; López-Sagaseta J
Acta Crystallogr D Struct Biol; 2022 Sep; 78(Pt 9):1156-1170. PubMed ID: 36048155
[TBL] [Abstract][Full Text] [Related]
30. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation.
Nguyen HL; Thai NQ; Nguyen PH; Li MS
J Phys Chem B; 2022 Jun; 126(25):4669-4678. PubMed ID: 35723978
[TBL] [Abstract][Full Text] [Related]
32. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
[TBL] [Abstract][Full Text] [Related]
33. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex.
Ching WY; Adhikari P; Jawad B; Podgornik R
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077490
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 omicron RBD forms a weaker binding affinity to hACE2 compared to Delta RBD in
Le HT; Tran LH; Phung HTT
J Biomol Struct Dyn; 2024 May; 42(8):4087-4096. PubMed ID: 37345564
[TBL] [Abstract][Full Text] [Related]
35. Missense mutations in spike protein of SARS-CoV-2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor.
Mahmood TB; Hossan MI; Mahmud S; Shimu MSS; Alam MJ; Bhuyan MMR; Emran TB
Immun Inflamm Dis; 2022 Sep; 10(9):e683. PubMed ID: 36039645
[TBL] [Abstract][Full Text] [Related]
36. Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2.
Chen C; Boorla VS; Banerjee D; Chowdhury R; Cavener VS; Nissly RH; Gontu A; Boyle NR; Vandegrift K; Nair MS; Kuchipudi SV; Maranas CD
Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34588290
[TBL] [Abstract][Full Text] [Related]
37. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
[TBL] [Abstract][Full Text] [Related]
38. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
F1000Res; 2020; 9():576. PubMed ID: 32802318
[No Abstract] [Full Text] [Related]
39. SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic.
Rostami N; Choupani E; Hernandez Y; Arab SS; Jazayeri SM; Gomari MM
J Cell Biochem; 2022 Feb; 123(2):417-430. PubMed ID: 34783057
[TBL] [Abstract][Full Text] [Related]
40. In silico study of SARS-CoV-2 spike protein RBD and human ACE-2 affinity dynamics across variants and Omicron subvariants.
Abeywardhana S; Premathilaka M; Bandaranayake U; Perera D; Peiris LDC
J Med Virol; 2023 Jan; 95(1):e28406. PubMed ID: 36519577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
